Latest Capital Structure News

Babylon Pump & Power reported a $7.16 million loss for H1 FY26, weighed down by acquisition-related expenses and an impairment charge, while its rental segment soared post-acquisitions.

Horizon Minerals has launched a Share Purchase Plan allowing eligible shareholders in Australia and New Zealand to buy additional shares between $2,000 and $30,000. The offer runs until 10 March 2026, with potential early closure depending on demand.

ZMM has reported a remarkable 253% increase in revenue for the half-year ending December 2025, yet still recorded a net loss of $1.078 million amid concerns over its financial sustainability.

Sprintex Limited reported a 162% surge in revenue to A$2.7 million for the half-year ending December 2025, driven by a landmark €15.6 million European contract. Despite this, the company posted a net loss of A$1.7 million, an improvement from the prior year, while raising $3.6 million to support global expansion.

Energy World Corporation has eliminated all group-level borrowings, strengthening its balance sheet and advancing key LNG and power projects in Southeast Asia amid ongoing operational losses.

FortifAI Limited reported a 51% revenue decline but a 70% reduction in net loss for H1 FY26, alongside completing a major AI technology acquisition and securing $5 million in fresh capital.

NEXTDC has reported a robust first half of FY26, with strong revenue and earnings growth underpinned by a surging forward order book and expanded capital expenditure plans.

Wisr Limited reports robust half-year growth with a 23% increase in its loan book and a 14% rise in revenue, setting the stage for expected cash profitability in the second half of FY26.

Iress Limited reported a 7.4% revenue decline to $556.3 million for FY25 but achieved a 21.5% rise in profit before tax, declaring a fully franked final dividend of 13 cents per share. The company sharpened its focus on core Wealth and Trading software businesses while advancing sustainability and AI innovation.

Imricor Medical Systems saw a sharp 69.5% decline in revenue for 2025, driven by clinical trial impacts, yet narrowed its net loss to $25.3 million as it secured FDA clearance for key products post-year-end.

Tian An Australia Limited reported a remarkable turnaround in FY2025, posting a statutory profit of $23.4 million on $84 million revenue, driven by the completion of The Henley, Enfield project and a significant gain from debt restructuring.

Metro has announced a significant share consolidation, reducing its total shares on issue from nearly 984 million to approximately 24.6 million. The move aims to streamline the capital structure ahead of trading resumption in early March.